167 related articles for article (PubMed ID: 16762556)
1. Protective activation of the endocannabinoid system during ischemia in dopamine neurons.
Melis M; Pillolla G; Bisogno T; Minassi A; Petrosino S; Perra S; Muntoni AL; Lutz B; Gessa GL; Marsicano G; Di Marzo V; Pistis M
Neurobiol Dis; 2006 Oct; 24(1):15-27. PubMed ID: 16762556
[TBL] [Abstract][Full Text] [Related]
2. Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo.
Pillolla G; Melis M; Perra S; Muntoni AL; Gessa GL; Pistis M
Psychopharmacology (Berl); 2007 Apr; 191(3):843-53. PubMed ID: 17334799
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity.
Hampson RE; Miller F; Palchik G; Deadwyler SA
Neuropharmacology; 2011 May; 60(6):944-52. PubMed ID: 21288475
[TBL] [Abstract][Full Text] [Related]
4. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors.
Melis M; Pistis M; Perra S; Muntoni AL; Pillolla G; Gessa GL
J Neurosci; 2004 Jan; 24(1):53-62. PubMed ID: 14715937
[TBL] [Abstract][Full Text] [Related]
5. Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons.
Melis M; Perra S; Muntoni AL; Pillolla G; Lutz B; Marsicano G; Di Marzo V; Gessa GL; Pistis M
J Neurosci; 2004 Nov; 24(47):10707-15. PubMed ID: 15564588
[TBL] [Abstract][Full Text] [Related]
6. CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats.
Rubio M; Fernández-Ruiz J; de Miguel R; Maestro B; Michael Walker J; Ramos JA
Neuropharmacology; 2008 May; 54(6):976-88. PubMed ID: 18371990
[TBL] [Abstract][Full Text] [Related]
7. The endocannabinoid 2-arachidonoylglycerol inhibits long-term potentiation of glutamatergic synapses onto ventral tegmental area dopamine neurons in mice.
Kortleven C; Fasano C; Thibault D; Lacaille JC; Trudeau LE
Eur J Neurosci; 2011 May; 33(10):1751-60. PubMed ID: 21410793
[TBL] [Abstract][Full Text] [Related]
8. CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus.
Béquet F; Uzabiaga F; Desbazeille M; Ludwiczak P; Maftouh M; Picard C; Scatton B; Le Fur G
Eur J Neurosci; 2007 Dec; 26(12):3458-64. PubMed ID: 18052990
[TBL] [Abstract][Full Text] [Related]
9. A role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy.
Eisenstein SA; Clapper JR; Holmes PV; Piomelli D; Hohmann AG
Pharmacol Res; 2010 May; 61(5):419-29. PubMed ID: 20044005
[TBL] [Abstract][Full Text] [Related]
10. Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus.
Di S; Boudaba C; Popescu IR; Weng FJ; Harris C; Marcheselli VL; Bazan NG; Tasker JG
J Physiol; 2005 Dec; 569(Pt 3):751-60. PubMed ID: 16239276
[TBL] [Abstract][Full Text] [Related]
11. Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport.
Ronesi J; Gerdeman GL; Lovinger DM
J Neurosci; 2004 Feb; 24(7):1673-9. PubMed ID: 14973237
[TBL] [Abstract][Full Text] [Related]
12. Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid Release in the Basolateral Amygdala.
Di S; Itoga CA; Fisher MO; Solomonow J; Roltsch EA; Gilpin NW; Tasker JG
J Neurosci; 2016 Aug; 36(32):8461-70. PubMed ID: 27511017
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine.
Vlachou S; Stamatopoulou F; Nomikos GG; Panagis G
Int J Neuropsychopharmacol; 2008 Nov; 11(7):905-23. PubMed ID: 18377702
[TBL] [Abstract][Full Text] [Related]
14. Endocannabinoid modulation of hyperaemia evoked by physiologically relevant stimuli in the rat primary somatosensory cortex.
Ho WS; Patel S; Thompson JR; Roberts CJ; Stuhr KL; Hillard CJ
Br J Pharmacol; 2010 Jun; 160(3):736-46. PubMed ID: 20590576
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoids exert CB
Xu C; Hermes DJ; Nwanguma B; Jacobs IR; Mackie K; Mukhopadhyay S; Lichtman AH; Ignatowska-Jankowska B; Fitting S
Mol Cell Neurosci; 2017 Sep; 83():92-102. PubMed ID: 28733129
[TBL] [Abstract][Full Text] [Related]
16. Bidirectional roles of the brain 2-arachidonoyl-sn-glycerol in the centrally administered vasopressin-induced adrenomedullary outflow in rats.
Shimizu T; Yokotani K
Eur J Pharmacol; 2008 Mar; 582(1-3):62-9. PubMed ID: 18234185
[TBL] [Abstract][Full Text] [Related]
17. Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling.
Fukudome Y; Ohno-Shosaku T; Matsui M; Omori Y; Fukaya M; Tsubokawa H; Taketo MM; Watanabe M; Manabe T; Kano M
Eur J Neurosci; 2004 May; 19(10):2682-92. PubMed ID: 15147302
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy.
Deshpande LS; Sombati S; Blair RE; Carter DS; Martin BR; DeLorenzo RJ
Neurosci Lett; 2007 Jan; 411(1):11-6. PubMed ID: 17110038
[TBL] [Abstract][Full Text] [Related]
19. Regulation of plasticity of glutamate synapses by endocannabinoids and the cyclic-AMP/protein kinase A pathway in midbrain dopamine neurons.
Haj-Dahmane S; Shen RY
J Physiol; 2010 Jul; 588(Pt 14):2589-604. PubMed ID: 20498231
[TBL] [Abstract][Full Text] [Related]
20. Search for an endogenous cannabinoid-mediated effect in the sympathetic nervous system.
Pfitzer T; Niederhoffer N; Szabo B
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):9-17. PubMed ID: 15660243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
